EcoDrugPlus

Protein Arginine Methyltransferase 5

Ensembl ID : ENSPLAG00000018154
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSPLAG00000006406
Gene Symbol: LOC106960880
3 Cross references
209 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSPLAG00000020578
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSPLAG00000013612
Gene Symbol: PRKCB
4 Cross references
78 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSPLAG00000012299
Gene Symbol: LOC106939953
3 Cross references
94 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSPLAG00000006932
Gene Symbol: PRKCD
3 Cross references
192 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSPLAG00000016257
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Epsilon Type-Like

Ensembl ID : ENSPLAG00000021670
Gene Symbol: LOC106948767
2 Cross references
245 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSPLAG00000014229
Gene Symbol: PRKCH
3 Cross references
224 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSPLAG00000017553
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSPLAG00000018493
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSPLAG00000023768
Gene Symbol: PRKD1
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).